Research
Metabolic adaptation
Intragastric balloons (IGBs) may improve steatosis and fibrosis in nonalcoholic fatty liver disease and improve quality of life and mental health in the short term.
Practitioners may consider IGBs as a short-term intervention for patients with nonalcoholic fatty liver disease.
StrongSupportsmedium confidence
In the short-term IGBs may improve steatosis and fibrosis in nonalcoholic fatty liver disease and improve quality of life and mental health.
Why this rating
The claim is supported by several studies confirming safety and efficacy.
Source
Endobariatrics: well past infancy and maturing rapidly
Shreesh Shrestha et al. · Current Opinion in Gastroenterology · 2022
DOI 10.1097/mog.0000000000000884
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Endoscopic sleeve gastroplasty (ESG) may be more effective and durable than intragastric balloons (IGBs) and result in fewer adverse events compared to bariatric surgery.Strong
- Aspiration therapy meets safety and effectiveness thresholds for incorporation into routine practice, but overall acceptance has been lower than other FDA-approved EBMTs.Good
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →